Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene

Pharmacogenetics and Genomics

Volumn 15, Issue 3, 2005, Pages 173-182

  Damaraju, Sambasivarao ^a,b   Zhang, Jing ^a   Visser, Frank ^a   Tackaberry, Tracey ^a   Dufour, Jennifer ^b   Smith, Kyla M ^a   Slugoski, Melissa ^a   Ritzel, Mabel W L ^a   Baldwin, Stephen A ^c   Young, James D ^a   Cass, Carol E ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Coding variants; Genomics; Integral membrane protein; Kinetics; Membrane transport; Nucleoside drugs; Nucleoside transporter; Polymorphism; Quantitative CNT3 protein expression; Sodium proton dependence

Indexed keywords

ADENOSINE; CYTIDINE; DNA; HUMAN CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3; INOSINE; NUCLEOSIDE TRANSPORTER; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; URIDINE;

ANIMAL CELL; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ELECTRODE; EXON; FLUORESCENCE; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRON; NONHUMAN; NUCLEOSIDE TRANSPORT; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; SACCHAROMYCES CEREVISIAE; SINGLE NUCLEOTIDE POLYMORPHISM; VOLTAGE CLAMP; WILD TYPE; XENOPUS LAEVIS; YEAST;

SACCHAROMYCES CEREVISIAE; XENOPUS LAEVIS;

EID: 20244373030     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01213011-200503000-00006     Document Type: Article

References (37)

1. Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, et al. Nucleoside transporters of mammalian cells. Pharm Biotechnol 1999; 12:313-352.
2. Vickers MF, Yao SY, Baldwin SA, Young JD, Cass CE. Nucleoside transporter proteins of Saccharomyces cerevisiae. Demonstration of a transporter (FUI1) with high uridine selectivity in plasma membranes and a transporter (FUN26) with broad nucleoside selectivity in intracellular membranes. J Biol Chem 2000; 275:25931-25938.
3. Cabrita MA, Baldwin SA, Young JD, Cass CE. Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes. Biochem Cell Biol 2002; 80:623-638.
4. Damaraju VL, Damaraju S, Young JD, Baldwin SA, Mackey J, Sawyer MB, et al. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy. Oncogene 2003; 22:7524-7536.
5. Cass CE. Nucleoside transport. In: Georgopapadakou NH (ed.) Drug Transport in Antimicrobial and Anticancer Chemotherapy. New York: Marcel Dekker; 1995:403-451.
6. +, nucleoside cotransporter (hCNT1). Am J Physiol 1997; 272:C707-C714.
7. +/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol 1998; 15:203-211.
8. +-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 2001; 276:2914-2927.
9. +-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). Mol Membr Biol 2001; 18:65-72.
10. Lang TT, Seiner M, Young JD, Cass CE. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells. Mol Pharmacol 2001; 60:1143-1152.
11. Mackey JR, Mani RS, Seiner M, Mowles D, Young JD, Belt JA, et al. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res 1998; 58:4349-4357.
12. Mackey JR, Jennings LL, Clarke ML, Santos CL, Dabbagh L, Vsianska M, et al. lmmunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin Cancer Res 2002; 8:110-116.
13. Spratlin J, Sangha R, Glubrecht D, Dabbagh L, Young JD, Dumontet C, et al. The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. Clin Cancer Res 2004; 10:6956-6961.
14. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22:231-238.
15. Iida A, Saito S, Sekine A, Nakamura Y. [SNP collection, pharmacogenomics, and the future of drug therapy]. Gan To Kagaku Ryoho 2002; 29: 1665-1673.
16. Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, et al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 2002; 62:4955-4962.
17. Lu X, Gong S, Monks A, Zaharevitz D, Moscow JA. Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity. J Exp Ther Oncol 2002; 2:200-212.
18. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409:928-933.
19. Gray JH, Owen RP, Urban TJ, Giacomini KM. Functional characterization of genetic variants of the nucleoside transporter, CNT1. Clin Pharmacol Ther 2003; 73:P59.
20. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J, et al. Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics 2003; 13:297-301.
21. Gray JH, Mangravite LM, Owen RP, Urban TJ, Chan W, Carlson EJ, et al. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations. Mol Pharmacol 2004; 65:512-519.
22. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci USA 2003; 100:5896-5901.
23. Gray JH, Owen RP, Giacomini KM. The concentrative nucleoside transporter family, SLC28. Pflugers Arch 2004; 447:728-734.
24. Badagnani I, Giacomini KM. Interaction of cladribine and fludarabine with genetic variants in the concentrative nucleoside transporter, CNT3 [abstract]. Am Soc Clin Pharmacol Ther 2004; 75:P18.
25. Zhang J, Visser F, Vickers MF, Lang T, Robins MJ, Nielsen LP, et al. Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae. Mol Pharmacol 2003; 64: 1512-1520.
26. Vickers MF, Kumar R, Visser F, Zhang J, Charania J, Raborn RT, et al. Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae. Biochem Cell Biol 2002; 80:639-644.
27. Visser F, Vickers MF, Ng AM, Baldwin SA, Young JD, Cass CE. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J Biol Chem 2002; 277:395-401.
28. Brunelli JP, Pall ML. A series of yeast shuttle vectors for expression of cDNAs and other DNA sequences. Yeast 1993; 9:1299-1308.
29. Ito H, Fukuda Y, Murata K, Kimura A. Transformation of intact yeast cells treated with alkali cations. J Bacteriol 1983; 153:163-168.
30. Vickers MF, Zhang J, Visser F, Tackaberry T, Robins MJ, Nielsen LP, et al. Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisae. Nucleosides Nucleotides Nucleic Acids 2004; 23:361-373.
31. +-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes. J Physiol 2004; 558:807-823.
32. Toan SV, To KK, Leung GP, de Souza MO, Ward JL, Tse CM. Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells. Pflugers Arch 2003; 447:195-204.
33. SenGupta DJ, Lum PY, Lai Y, Shubochkina E, Bakken AH, Schneider G, et al. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry 2002; 41:1512-1519.
34. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 2003; 100:5902-5907.
35. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002; 12:436-446.
36. +-nucleoside cotransporter rCNT1. J Biol Chem 2001; 276:27981-27988.
37. Damaraju S, Sawyer M, Zanke B. Genomic approaches to clinical drug resistance. Cancer Treat Res 2002; 112:347-372